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ABSTRACT 
 
Preparation and characterization of soy lecithin (SL) and palm oil (PO) based organogels have 
been reported in this study. The optimization of the composition of the organogels was carried 
out by varying the proportions of SL, PO and water. Microscopic studies suggested the presence 
of aqueous phase either as fluid filled fibers or spherical droplets or both, depending on the 
composition of the organogels. FTIR study indicated strong intermolecular hydrogen bonding 
amongst the organogel components. The pHs of the organogels was found to be ~ 5.75 and were 
hemocompatible. The release of metronidazole (MZ; model drug) suggested diffusion mediated 
drug release. MZ loaded organogels have shown good antimicrobial property against B. subtilis 
and E. coli. 
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1. INTRODUCTION 
Organogels are semisolid formulations which consist of apolar solvent as the liquid phase. They 
are often reported to be thermo-reversible and may be attributed to the physical interactions 
amongst the gel components [1-3]. Permanent organogels have also been reported [2].  
Organogels have been found to be inherently thermodynamically stable below their gellation 
temperature. They possesses viscoelastic properties which is suitable for the development of 
topical/ transdermal formulations [1]. The properties of organogels may be tailored by 
incorporating water within its structure [4]. Sagiri et. al. (2012) showed that by varying the 
composition of organogels, it is possible to alter the drug release profile from the organogels. 
Due to the above-mentioned properties, there has been an increased research to device controlled 
drug delivery systems based on organogels [5].  
Lecithin appears as a combination of zwitter ionic phospholipids (namely, phosphotidyl choline, 
phosphotidyl ethanolamine and phosphotidyl inositol), which forms either spherical or 
ellipsoidal reverse micellar structures when added to oil [5]. Addition of water into these apolar 
solutions results in the many-fold increase in the viscosity [6]. If the composition of the 
formulation is correct, the tri-phasic system forms organogels else remain as liquid mixtures [7]. 
Lecithin organogels have been reported to be thermo-reversible in nature and have a gel-to-sol 
transition of ~40
°
C [8]. The lecithin based organogels have also been reported to be viscoelastic 
in nature, an essential entity for the development of topical formulations [8].  
Palm oil (PO) is extracted from the mesocarps and kernels of the fruits of the palm tree Elaesis 
guineenis and is rich in C16 and C18 fatty acids [9-10]. PO is rich in saturated fatty acids and has 
been found to be highly stable against oxidation. Due to this reason, PO has evolved as a suitable 
candidate to be used for topical formulations. Sakeena et. al. (2010) has reported the use of PO 
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ester based nanoemulsion of ketoprofen for topical application [11]. Owen et. al. (2000) has 
developed contraceptive gel using PO [12].   
Taking inspiration from the above, it seems quite justified to develop PO and lecithin based 
organogels. Hence, an attempt was made to develop and characterize PO and soy lecithin (SL) 
based organogels. The developed organogels were tested as matrices for controlled delivery of 
metronidazole (MZ).  
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2. Literature Review 
A semi-solid formulation having an external solvent and apolar phase immobilized within a three 
dimensional networked structure is known as gel [3]. The organogels are bi-continuous systems 
consisting of gelators, apolar and polar solvent[1]. The gelator molecule undergoes physical or 
chemical transformations to form fibrous structures which get entangled with each other to form 
three-dimensional networked structure. The three-dimensional networked structure, immobilize 
the flow of external apolar phase [2]. 
Lecithin is a zwitter ionic phospholipid with two alkyl tails, when added to oil forms spherical or 
ellipsoidal reverse micelles. It is having three phospholipids i.e. phosphotidyl choline (PC), 
phosphotidyl ethanolamine (PE) and phosphotidyl inositol (PI) [7]. Different polar solvents such 
as glycerol, formamide and ethylene glycol, in addition to water have been studied to check the 
ability to induce organogel. The infra red results reveal that molecules of both the gel-forming 
solvents and non-gel-forming ones are attached to the lecithin phosphate group through hydrogen 
bonds [13].  
Lecithin organogel is having a unique property of micelle formation. The micellar aggregates, 
much like the polymer molecules, overlap, interpenetrate, entangle, thus forming a temporal 
three-dimensional network that brings about viscoelastic properties. For this reason, the micellar 
system is in a jelly-like state [14]. It is widely used in everyday life, including human and animal 
food, medicine, cosmetics and manifold industrial applications due to the formation of the lipid 
matrix which plays a key role in the cellular metabolism[14].  
Some organic solvents e.g. ether, linear, branched and cyclic alkanes, esters and amines  have 
been used with lecithin in order to form organogels [14-15]. But due to toxicity of these apolar 
solvent recently oils such as palm oil, sun flower oil, soybean oil, mustard oil have been used to 
form organogels [3, 16].  
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Palm oil is made up mostly of glyceridic materials with some non glyceridic materials in small or 
trace quantities. Triglycerides and fatty acids composition triglycerides form the major 
component and bulk of the glyceridic material present in the palm oil with small amount of 
monoglycerides. Fatty acids chains present in the chain and in the structure [9-10]. So thus it 
makes palm oil a good apolar solvent in the preparation of organogel and also in the drug 
delivery.  
The phase behavior of lecithin in n-decane employing water as the polar solvent has been 
discussed [14]. At first, with the addition of water, the thickening effect is observed at a certain 
specific molar ratio of water to lecithin. After this threshold concentration, further addition of 
water leads to a sharp increase in the viscosity and the formation of organogel [5].  
The topical administration of drugs cutaneous and percutaneous drug  delivery has recently got 
high importance as they are having easy noninvasive administration, local enhanced transdermal 
delivery, avoidance of local  gastrointestinal toxicity and delivery benefits [17]. In a recent 
development, phospholipids in addition with some other additives such as water or apolar solvent  
have been shown to provide a very promising topical drug delivery medium known as lecithin 
organogels [17].  
SL organogels have generated considerable interest over the years as a potential topical drug 
delivery vehicle [18].  One of the important applications of SL organogel is topical delivery. Due 
to existence of aqueous and organic phase, larger interfacial area, well defined structure, 
entrapment of solutes within the gel matrix and ability to form micells make it good topical drug 
delivery vehicle.  
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3. MATERIALS AND METHODS 
3.1. MATERIALS 
Soy lecithin (SL) was purchased from Otto India Pvt. Ltd., Kokata, India. Edible PO was 
purchased from the local market. Trisodium citrate was purchased from Loba Chemie Pvt. Ltd., 
Mumbai, India. Nutrient agar and dialysis tubing (MW cutoff: 60 kDa) were procured from 
Himedia, Mumbai, India. Microbial cultures of Bacillus subtilis (NCIM 2699) and Escheratia 
coli (NCIM 2563) were obtained from National Collection of Industrial Microorganisms 
(NCIM), Pune, India. MZ was received as a gift from Aarti drugs, Mumbai, India. Goat blood 
was collected from the local butcher shop. Double distilled water (DW) was used throughout the 
studies. 
 
3.2. METHODS 
3.2.1. Preparation of organogels 
SL and PO based organogels were prepared by fluid fiber mechanism. The optimization of the 
organogels formation was carried out by varying the proportions of SL, DW and PO. A ternary 
phase diagram was plotted to have an overview of organogel forming area. The development of 
organogels was carried out as per the method reported by our group for the development of span 
80/ tween 80 and SL based organogels with slight modifications [16, 19]. In short, accurately 
weighed SL was taken in culture tube and was dissolved in specified weight of PO (apolar 
solvent). The mixture was subsequently incubated at 70 
o
C for 5 min in a water-bath. Specified 
amount of DW, maintained at 70 
o
C, was added drop-wise to the SL-PO solution with constant 
vortexing to obtain a homogeneous mixture. The homogenous mixture was allowed to cool to 
room temperature (RT, 25 
o
C). The formation of gel was confirmed by tube inversion method.  
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3.2.2. Oraganoleptic Evaluation 
Freshly prepared organogels were evaluated for organoleptic properties (e.g. odor, color, taste, 
appearance and texture) [20].  
 
3.2.3. Stability studies 
3.2.3.1. Accelerated stability Test 
Freeze-thaw method was used to predict the long-term stability of the organogels. The gels were 
incubated alternatively in the water bath (maintained at 70 
o
C) and temperature controlled 
cabinet (maintained at - 4 
o
C) for 15 min each. The procedure was repeated for five cycles.  After 
each cycle, gels were inspected for any signs of destabilization. The samples were regarded to be 
stable if they survived the harsh conditions for 5 cycles [19]. 
 
3.2.3.2. Intermediate stability test 
The stability of the pharmaceutical products may be carried out by incubating the samples at a 
particular environment for a longer time period. International Conference on Harmonisation 
(ICH) guideline of stability of pharmaceutical products indicates the storage of the products at 
30°C ± 2°C/65% RH ± 5% RH for 6 months (intermediate stability test) [21].  
 
3.2.4. Microscopic studies 
The microstructures of the gels were studied in detail by bright field microscopy (BFM; LEICA-
DM 750 equipped with ICC 50-HD camera), phase contrast microscopy (PCM; Carl Zeiss, 
Model HBO 50, Germany) and scanning electron microscopy (SEM; Jeol JSM-6480LV, Japan) 
[22-23]. The BFM and PCM were carried out by making thin smears of the organogels. The thin 
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smears were dried in an oven at 45 
o
C for 12 h and were reanalyzed under PCM. The SEM 
studies were conducted by converting the organogels into xerogels as per the reported literature 
[24]. The xerogels were sputter-coated with platinum before the SEM studies [25].  
 
3.2.5. pH measurement 
The pH of the optimized organogels was measured using a digital ATC pH meter (EI 
instruments, model no- 132E) [26]. 
 
3.2.6. FTIR spectroscopy 
The functional group identification and interaction, if any, amongst the components of the 
developed gels were studied by ATR-FTIR spectrophotometer (AlphaE ATR-FTIR, Bruker, 
USA). The scanning was done in the range of 4000 cm
-1
 to 500 cm
-1
 [27].  
 
3.2.7. Disintegration studies 
Tablet disintegration apparatus (Electronics, Model 901, Mumbai, India) was used to study the 
disintegration behavior of the organogels. The tests were conducted as per the reported literature 
[28]. In short, pellets of organogels (~1 g) were prepared by incubating the organogels at -20 
o
C 
for 30 min. The test was carried out in two disintegration fluids to simulate the gastric (SGF; 
0.01 N HCl, pH=2.0) and intestinal (SIF; phosphate buffer saline of pH=6.8) conditions at 37 ±1 
ºC. The total time taken for the complete disintegration of the organogels was noted as the 
disintegration time [28]. 
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3.2.8. Gel Sol Transition Test 
Gel-sol transition temperature was found out by incubating the organogels in a water bath, whose 
temperature was varied from 27-50 ºC. The temperature, at which the gels started to flow, when 
the glass vials were inverted, was noted as the gel-sol transition. 
  
3.2.9. Hemocompatibility studies 
The hemocompatibility study was carried out to find out the extent of hemolysis of the blood 
cells in the presence of the leachants of the developed organogels. The method has been 
described in details elsewhere [29].  The method deals with the incubation of the leachants of the 
organogels with the goat blood and analyzing the % hemolysis of the goat blood. The % 
hemolysis was calculated as per the formula given below [30-31]:  
% 100
test Negative
positive Negative
OD OD
Hemolysis
OD OD

 

     
 
where, ODTest = optical density of test sample, OD Positive = optical density of +ve control and 
ODNegative= optical density of -ve control.   
 
3.2.10. In-vitro Drug Release 
In-vitro drug release was carried out using a 2-compartment modified Franz’s diffusion cell as 
per the previously reported literature [32]. In short, accurately weighed ~1 gm of MZ containing 
organogels were taken in the donor chamber. 50 ml of DW was used as the dissolution medium 
and was kept in the receptor chamber. The receptor volume was stirred at 100 rpm at constant 
temperature 37 ± 1 °C. Previously activated dialysis membrane of MW cut-off - 60 kDa, 
obtained from Himedia, Mumbai, was used as the semipermeable membrane. The release study 
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was conducted for a period of 12 h. The whole receptor volume was changed periodically (15 
min for first 1hr, 30 min for the next 2 h and 1 h for the next 9 h) with fresh DW. A portion of 
the replaced DW was further analyzed under UV- spectrophotometer (UV 3200 double beam, 
Labindia) at a wavelength of 321 nm [21]. The drug release studies were carried out in duplicate 
[33-34]. 
 
3.2.11. Antimicrobial assay 
Antimicrobial assay was performed using bore well method. The antimicrobial efficacy of the 
MZ loaded organogels were studied against Bacillus subtilis (gram positive bacteria) and 
Escherichia coli (gram negative bacteria). Nutrient agar was used as a culture media for the 
study. 0.1 g of sample were accommodated in the wells of diameter 5 mm, which was bored 
using a sterilized borer.1 ml of nutrient broth cell suspension containing 10
6
 to10
7 
cfu/ml of 
bacteria was spread on the solid nutrient agar Petri plates using a sterilized spreader. The zone of 
inhibition was measured after the plated were incubated for 24 h at 37 ± 1 °C.  
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4. RESULTS AND DISCUSSIONS 
 
4.1. Preparation of Organogels 
SL and PO based organogels were developed by varying the proportions of SL, PO and DW. The 
organogels were formed by fluid filled fiber mechanism [3]. Depending on the composition of 
the mixture of SL, PO and DW, the mixture either formed organogels or remained as liquid 
mixtures [35]. It was further confirmed by tube inversion method [35]. Depending on the 
composition of the organogels, the color of the developed organogels varied from cream color to 
dark brown color. The developed organogels were opaque in nature and were non-birefringent 
[3]. Apart from the organogels, emulsions were also formed when the concentration of SL was in 
between 10 % and 30 %. Figure 1 shows the compositions of the mixtures of the SL, PO and 
DW which resulted in the formation of organogels and emulsions.  The organogels formation 
was observed when the concentrations of SL, DW and PO were in the range of ~43 % - ~80 %, 
~17% - 55% and ~2% to 20%, respectively.  Emulsions were formed when the concentrations of 
SL, DW and PO were in the range of ~10 % - ~25 %, ~45 % – ~60 % and ~25% to ~35% w/w 
(Figure 2). 
 
 
 
 
 
 
Figure 1: Mechanism of organogel and emulsion formation  
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Figure 2: Mapping of the compositions forming organogels and emulsions  
4.2. Organoleptic Evaluation 
The color of the developed organogels was found to be varying from cream to brown in color. 
The emulsions were light brown in color. The consistencies of the organogels were improved 
with the increase in SL concentration. All the samples were found to be oily to touch and 
possessed pleasant odor.  
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4.3. Stability Studies 
4.3.1. Accelerated Stability Test 
Accelerated stability test was conducted by freeze-thaw method to have an understanding about 
the long-term stability of the organogels. The samples were observed for any signs of 
destabilization (e.g. phase separation, change in color or odor) during the course of the study. All 
the emulsions failed the accelerated stability test and hence were not studied further. Some of the 
developed organogels formulations have failed the test (marked in red, Figure 3) The 
formulations failed to maintain their structural integrity and started to flow. Rest of the organogel 
formulations have passed test. From the triplot it was clear that the organogels which failed the 
accelerated stability test were having compositions near to the critical gellation concentration 
(figure 3). 5 organogel formulations were selected from the stable formulations as representative 
samples for further characterization. 1 % MZ was incorporated within these selected organogels. 
The compositions of the representative organogels and their corresponding drug incorporated 
organogels have been provided in table 1.  
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Figure 3: Mapping of the compositions of the formulations after accelerated stability test  
 
 
 
 
 
 
 
 
 
 
Figure 4: Representative organogel formulations after the accelerated stability test. (a) 
Stable organogel and (b) and Destabilized organogel 
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Table 1: Composition of the organogels used for further analysis 
Formulations SL (% w/w) PO (% w/w) DW (% w/w) MZ (% w/w) 
PLG1 45 10 45 - 
PLG1M 45 10 44 1 
PLG2 60 7.5 32.5 - 
PLG2M 60 7.5 31.5 1 
PLG3 60 15 25 - 
PLG3M 60 15 24 1 
PLG4 70 5 25 - 
PLG4M 70 5 24 1 
PLG5 70 10 20 - 
PLG5M 70 10 19 1 
 
4.3.2. Long term stability test 
All the selected formulations were kept for long-term stability test. The organogels were 
incubated at 30 °C ± 2 °C and 75% ±5% RH for 12 months.  All the samples passed the test with 
no change in the physical appearance i.e. change in color, phase separation or syneresis of the 
organogels.  
 
4.4. Microscopic studies 
The microstructures of the organogels have been shown in figure 5. When the concentration of 
the SL was lowest (~45 %), uniformly distributed spherical-shaped droplets were observed. The 
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distribution pattern of the dispersed droplets became uneven when the concentration of SL was 
increased. With the further increase in the SL to ~70 %, a network of fiber-like structures was 
observed. This may be attributed to the supramolecular structure of the lecithin molecules [14].   
 
Figure 5: Bright field micrographs of the organogels showing the dispersed phase 
structures.  
 
4.5. pH measurement 
The normal pH of the human skin varies in the range of 5.5-7.0. The pH of the developed 
organogels formulations were found to be in range of 5.6 to 5.75 (table 3). The results indicated 
that the formulations might be used for topical applications. 
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Table 2: pH value of the selected organogels 
S. No. Sample pH value 
1 PLG1 5.61 ± 0.12 
2 PLG2 5.63 ± 0.16 
3 PLG3 5.71 ± 0.18 
4 PLG4 5.75 ± 0.11 
5 PLG5 5.73 ± 0.10 
 
4.6. FTIR spectroscopy 
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Figure 6: FTIR study of raw material and their MZ loaded gels 
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FTIR spectrograms of the raw materials (SL and PO) and the organogels (blank and drug loaded) 
have been shown in figure 9. SL showed a broad peak at ~3600 cm
-1
 due to the -OH stretching 
vibrations [16]. The absorption peaks at ~ 2848 cm
-1 
and ~ 1461 cm
-1 
may be associated to the C-
H stretching and bending vibrations, respectively, of the alkanes. The absorption peak at ~ 1745 
cm
-1 
may be associated to the -CO stretch of the carbonyl groups. The peaks at ~ 721 cm
-1 
may 
be associated to the CH rocking due to the alkanes [14, 16] . PO has shown the absorption peaks 
at ~2920 cm
−1
 and ~2850 cm
−1
 which was associated  to the CH stretching  in CH3 and CH2 of 
alkanes [36]. The absorption peaks at ~ 1470 cm
−1
 was due to the CH2 scissoring vibrations [37]. 
The peak at ~1743 cm
−1
 may be associated with the stretching vibration of CO group of 
triglycerides present in PO [38]. MZ has shown absorption peak at ~3220 cm
−1 
which may be 
associated with the OH stretching. The absorption peak at 3,100 cm
−1
 may be attributed to C–H 
stretching vibration. The absorption peak in the range of 1400–1535 cm−1 may be accounted to 
the functional groups present in the imidazole ring [39]. The peak at 1348 cm
−1 
was attributed to 
the NO symmetrical stretch of imidazole. The absorption peak at 1732 cm
−1
 may be associated 
with the C=C double bond [40]. The FTIR spectra of the organogels have shown the presence of 
absorption peaks corresponding to the raw materials. A slight shift was observed in few 
absorption peaks which may be explained due to the change in the chemical environment around 
the components of the organogels. A broad peak was observed at ~ 3350 cm
-1
 which suggested 
the presence of strong intra-molecular/ intermolecular hydrogen bonding amongst the organogel 
components. The increase in the intensity as compared to the raw materials indicated an increase 
in the hydrogen bonding amongst the gel components [7, 16]. No extra peak was observed in the 
MZ loaded organogels. This may due to the fact that MZ was present in very minute 
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concentrations and the peaks associated with MZ were subsided because of the intense peaks of 
the other components.   
 
4.7. Disintegration Test 
Table 9 shows the time required for the complete disintegration of the organogels in SGF and 
SIF. In general, the disintegration time of the organogels in both the simulated fluids was 
dependent on the concentration of the DW. There was an increase in the disintegration time of 
the organogels with the decrease in the DW concentration except PLG4.  The disintegration time 
of PLG4 was highest amongst all the gels and did not follow the trend. The results indicated that 
PLG4 may be used as a carrier for controlled delivery of bioactive agents for prolonged period of 
time whereas PLG1 may be a good carrier for the delivery of drugs where quicker release of 
drugs are required [24, 41]. 
 
Table 3: Disintegration test of the selected gels 
 Disintegration time 
 
Formulations pH 1.2 pH 6.8 
PLG1 58 min 1 h 11 min 
PLG2 2 h 2 min 3 h 25 min 
PLG3 1 h 58 min 3 h 25 min 
PLG4 3 h 20 min 4 h 
PLG5 2 h 30 min 2 h 21 min 
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4.8. Gel Sol Transition: 
Table 7: Gel-sol transition of the optimized organogels 
Formulations 25
0
C 30
0
C 35
0
C 40
0
C 45
0
C 50
0
C 55
0
C 
PLG 1 √ √ √ √ X X X 
PLG 2 √ √ √ √ √ √ X 
PLG 3 √ √ √ √ √ X X 
PLG 4 √ √ √ √ √ √ X 
PLG 5 √ √ √ √ √ X X 
 
Gel-sol transition showed the melting point of the developed organogels was in the range of 45 
to 55
0
C (table 7). The MP of the gels was found to be increased with SL concentration 
suggesting presence of surfactant might have increased the structural integrity. At the same time 
it may also be concluded that presence of water also imparted an increase in the structural 
organization of the gel samples. PLG 2 has shown higher melting point as compared to PLG 3 
which may be associated to the higher DW concentration in PLG2 as compared to PLG3. Both 
PLG2 and PLG3 possessed equal SL concentration. So it might be the DW which might have 
increased the inter molecular hydrogen bonding.  
 
4.9. Hemocompatibility Test 
The results of the hemocompatibility test have been tabulated in the table 12. The results 
suggested that the organogels were highly hemocompatible in nature. 
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Table 5: Hemocompatibilty test 
Sample Name % Hemolysis 
PLG1 3.05 ± 0.08 
PLG2 1.42 ± 0.04 
PLG3 3.55 ± 0.09 
PLG4 0.00 ± 0.00 
PLG5 0.00 ± 0.00 
  
4.10. In- vitro drug release 
The drug release profiles of MZ from the organogels have been shown in figure 7. The results 
suggested that the release of the drug was dependent on the composition of the organogels. The 
cumulative percentage drug release (CPDR) of MZ from the organogels was in the order of 
PLG1M > PLG2M > PLG3M > PLG4M > PLG5M. This indicated that the CPDR of the drug 
was lowered due to the combined effect of the decrease in the concentration of DW and an 
increase in the concentration of SL. 
34 
 
 
Figure 7: CPDR of the developed gels 
 
4.11. Antimicrobial assay 
The efficiency of the drug incorporated organogels was studied against B. subtilis (a model gram 
positive bacterium) and E. coli (a model gram negative bacterium). The zone of inhibition was 
measured after 24 h of incubation at 37 ± 1 °C. Metrogyl, the marketed MZ gel, was taken as the 
positive control whereas the blank gels were treated as the negative controls. The results 
indicated that the developed organogels have shown good antimicrobial efficacy against the 
gram positive and gram negative bacterium and the antimicrobial efficiency was comparable to 
the marketed formulations (Figure 8-9).  
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Figure 8: Antimicrobial efficacy of the organogels against E. coli  
 
 
 Figure 9: Antimicrobial efficacy of the organogels against B. subtilis  
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5. CONCLUSION 
This study reports the successful development of the SL and PO based organogels. The 
preliminary study suggested that the developed systems may be used as potential carriers for 
bioactive agents. The organogels were easy to prepare and had shown excellent thermal stability. 
The disintegration test suggested the developed systems may be used either as a controlled 
release system or as a quick release system, depending on the composition of the organogel. The 
developed organogels were found to have good spreadability and viscosity profile desired for the 
development of topical formulations. The organogels were found to be highly biocompatible. 
The antimicrobial assay of the MZ-loaded organogels has shown comparable antimicrobial as 
against Metrogyl
®
. In short, it may be concluded that the developed organogels may be used as 
carriers for antimicrobial bioactive agents for topical application. 
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